Akèy › Grip
Etid klinik pou Grip ap rekrite nan Etazini
39 etid pou Grip ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Atlanta, GA9 etid
- Washington, DC7 etid
- Chicago, IL5 etid
- Philadelphia, PA5 etid
- Charlottesville, VA5 etid
- Houston, TX4 etid
- Seattle, WA4 etid
- Durham, NC4 etid
- Baltimore, MD4 etid
- Salt Lake City, UT4 etid
- St. Louis, MO4 etid
- Hialeah, FL4 etid
- Kansas City, MO3 etid
- Winston-Salem, NC3 etid
- Columbus, OH3 etid
- Torrance, CA3 etid
- Miami, FL3 etid
- Rochester, NY3 etid
- San Diego, CA3 etid
- Portland, OR3 etid
Pa eta
- Alabama5 etid
- Arizona3 etid
- Arkansas3 etid
- Connecticut3 etid
- Florid7 etid
- Georgia10 etid
- Idaho3 etid
- Illinois7 etid
- Kalifòni10 etid
- Kansas3 etid
- Lwizyàn4 etid
- Maryland9 etid
- Michigan3 etid
- Missouri6 etid
- New York5 etid
- North Carolina5 etid
- Ohio5 etid
- Oregon3 etid
- Pennsylvania8 etid
- South Carolina3 etid
- Tennessee4 etid
- Texas8 etid
- Utah4 etid
- Virginia5 etid
- Washington4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06160128BPL-1357 Against H1N1 Influenza Virus Challenge
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Sep 30, 2026 · NCT07215858pH1N1 Blinded Challenge Study
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Sep 25, 2026 · NCT07110532High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
Ap rekriteFaz 2
Laj 3 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT05947071A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
Ap rekriteFaz 3
3 Weeks – 11 Years · Tout sèks · Mizajou Sep 24, 2026 · NCT06094010Optimizing Lymphatic Pumping for Influenza Vaccine Responses in Vulnerable Populations
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07786467Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 22, 2026 · NCT01386424A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Ap rekriteFaz 3Volontè an sante akeyi
Laj 65 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07805707Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 50 · Tout sèks · Mizajou Sep 15, 2026 · NCT06863142Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07779408Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 9, 2026 · NCT04772170Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05624450Dime La VerDAD: Verify, Debunk, and Disseminate
Ap rekriteVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Aug 26, 2026 · NCT06417762Respiratory Virus Sampling and Repository
Ap rekriteEtid obsèvasyon
Laj 3 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05266222Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 65 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06029933Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT04712539The Effects of Endotracheal Suctioning on Pain and Serum Markers
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT06692400A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
Ap rekriteFaz 1
Laj 65 a 85 · Tout sèks · Mizajou Jun 30, 2026 · NCT07464314Flu Infection at UPHS
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT06807840First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 59 · Tout sèks · Mizajou May 11, 2026 · NCT07169318A Study to Learn About mRNA Vaccines Against Influenza in Adults
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT07431853Woodsmoke Exposure, Influenza Infection, and Nasal Immunity
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 a 49 · Tout sèks · Mizajou Apr 30, 2026 · NCT06841913H5N1 Milk Detection Study
Ap rekriteVolontè an sante akeyi
Laj 18 a 64 · Tout sèks · Mizajou Apr 15, 2026 · NCT06850298The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
Ap rekriteVolontè an sante akeyi
6 Months – 99 Years · Tout sèks · Mizajou Apr 8, 2026 · NCT05832307MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Ap rekriteFaz 2
Jiska laj 60 · Tout sèks · Mizajou Apr 6, 2026 · NCT05735717Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.